Cirrhosis Clinical Trial
Official title:
Metabolic and Nutritional Assessment in Patients on the Waiting List for Liver Transplantation
Metabolic disorders and malnutrition are well known and have been reported in patients with chronic liver disease, but the relationship of energy metabolism and changes in nutritional status in patients on the waiting list for liver transplantation are unexplored. The aim of this study was to assess the resting energy expenditure (REE) of these patients, identifying the prevalence of hyper and hypometabolism. In addition, to assess if, malnutrition and clinical variables were associated with REE and metabolic disorders.
This cross-sectional and descriptive study was carried out at the Alfa Institute of
Gastroenterology, Hospital of Clinics, Universidade Federal of Minas Gerais (UFMG). The
research protocol was approved by the UFMG Ethics Committee. Patients with indication for
liver transplantation, aged over 20 years who regularly attended the Liver Outpatient
Transplant Clinic were included after having agreed and signed the informed consent form.
The presence of endocrine abnormalities (hyper/hypothyroidism) and patients on the waiting
list for a double or re-transplant were excluding conditions. The REE and nutritional status
assessment were performed by the same trained investigator (LGF) in order to reduce errors.
Resting Energy Expenditure - REE was measured by indirect calorimetry using a gas analyzer
K4b2 (Cosmed, Rome, Italy). The test was performed in a silent, temperature-controlled room
(22-24oC) in the morning, between 08:00am and 09:30am. The patients fasted for 12 hours, and
remained on the lying position for about 20 minutes before the beginning of the test. The
device was calibrated before each exam. The volume of inspired oxygen (VO2) and exhaled
carbon dioxide (VCO2) was collected through a turbine and a sample line, adapted to the face
mask, applied to the patient and, connected to the unit. The collection of gases occurred
for 25 minutes, and the first 5 minutes were discarded. The mean VO2 and VCO2 per minute
were used to calculate the REE according to the Weir formula. The obtained data were
multiplied by 1,440 to obtain the 24-hour REE. Therefore, the REE was divided by kilograms
of fat free mass - FFM (REE/FFM). Predicted REE was calculated from the Harris and Benedict
formula (REEHB). In patients with fluid retention (clinical evidence of ascites and/or limb
edema) dry weight was calculated by deducting an estimated weight for ascites and/or limb
edema. Hypermetabolic patients were identified if the ratio REE:REEHB was > 120% and
hypometabolic patients were classified according to the ratio REE:REEHB < 80%. The
non-protein respiratory quotient (RQ) was calculated by the formula VCO2/VO2. Oxidation
rates of carbohydrate and fat were expressed as percentages of total generated energy.
Nutritional Assessment - Nutritional status was provided by the Subjective Global Assessment
(SGA), anthropometric measurements, handgrip strength, bioimpedance and energy balance (EB)
analyses. The SGA adapted for patients on the waiting list for liver transplantation is
based on clinical history and physical examination, as well as the presence of existing
conditions such as encephalopathy, chronic or recurrent infection, varicose veins and renal
function. Patients were classified as nourished and those classified as suspected or
moderately malnourished and severely malnourished were grouped together to form the
malnourished group.
Anthropometric evaluation was comprised of weight, height, body mass index (BMI), triceps
and subscapular skinfold thickness (TSF and SSF respectively, measured with the Lange
Skinfold Caliper - Cambridge Scientific Industries Inc., Cambridge, MD, USA), midarm
circumference (MAC, measured with inextensible tape), arm muscle area (AMA) and arm fat area
(AFA). To minimize practical variability, the average of three consecutive measurements was
recorded. Values of TSF, SSF, MAC, AMA and AFA below the 5th percentile and BMI below
18.5kg/m2 (or 22.0kg/m2 for elderly) were considered as malnutrition.
Handgrip strength (HS) was assessed with the Jamar Handgrip Dynamometer (Preston, Jackson,
MI, USA) using the non-dominant arm, and the mean of three measurements was determined.
Malnutrition was defined as values of HS below the 5th percentile.
Bioelectrical impedance analysis (Quantum X - RJL Systems, Inc., Clinton Township, Michigan)
was used to determine body composition. Measurements were made with patients lying in bed
with 4 electrodes attached to the dorsum of the right hand and foot. Phase angle (PA), fat
mass (FM - kg), fat free mass (FFM, kg), total body water (TBW - L), intracellular water
(ICW - L) and extracellular water (ECW - L), were evaluated. PA was categorized in equal to
or less than 5.4o, or above 5.4o as proposed by Selberg et al.
The energy balance (EB) was obtained by subtracting the total energy expenditure from the
total caloric intake (TCI). The TEE was obtained by multiplying the 24-hour REE by the
calculated activity factor (AF), which was based on the description of the patients' daily
activities and the corresponding computed values of metabolic equivalents (METs). Food
intake was assessed by a 3-day food record (DietPro5i® Agromídia Software, Viçosa, Brazil).
Clinical and other variables - Age, sex, etiology, severity of liver disease by the
Child-Pugh score (22) and the Model for End Stage Liver Disease score (MELD), complications
like presence of fluid retention and hepatic encephalopathy; number of medication and
diuretics; β-blockers and lactulose use were all compiled. Diagnosis of liver cirrhosis was
based of clinical, biochemical and histopathological data. The indications for liver
transplantation were categorized into alcoholic cirrhosis, viral and other diseases. Liver
function tests (aspartate aminotransferase - AST, alanine aminotransferase- ALT, total
bilirubin-TB and international normalized ratio-INR), presence of diabetes and/or glucose
intolerance (24) and fasting glucose were also investigated.
;
Observational Model: Case-Only, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01884415 -
Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis
|
Phase 3 | |
Recruiting |
NCT05014594 -
Sodium-glucose Linked Transporter 2 (SGLT-2) Inhibitors in Recurrent Ascites: a Pilot RCT
|
Phase 2 | |
Not yet recruiting |
NCT03631147 -
The Effect of Rifaximin on Portal Vein Thrombosis
|
N/A | |
Completed |
NCT04939350 -
Evaluation of the Vaccination Coverage of Cirrhotic Patients Followed in the General Hospitals in France in 2021
|
||
Completed |
NCT02528760 -
To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill Cirrhosis
|
N/A | |
Recruiting |
NCT05484206 -
Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434
|
Phase 1 | |
Not yet recruiting |
NCT05538546 -
Baveno VI Criteria in Dynamic Monitoring of High-risk Varices in Compensated Cirrhotic Patients
|
||
Not yet recruiting |
NCT04053231 -
Hepatocarcinoma Recurrence on the Liver Study - Part2
|
||
Recruiting |
NCT02983968 -
Use of the French Healthcare Insurance Database
|
||
Completed |
NCT02705534 -
Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1
|
Phase 3 | |
Completed |
NCT02596880 -
Sofosbuvir, Daclatasvir, Ribavirin for Hepatitis C Virus (HCV) Cirrhotics
|
Phase 3 | |
Completed |
NCT02247414 -
Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection
|
Phase 4 | |
Completed |
NCT02016196 -
Rifaximin vs Placebo for the Prevention of Encephalopathy in Patients Treated by TIPS
|
Phase 3 | |
Withdrawn |
NCT01956864 -
Study of High-Dose Oral Vitamin D for the Prevention of Liver Cancer
|
Phase 1 | |
Completed |
NCT02113631 -
Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir
|
N/A | |
Completed |
NCT01447537 -
Mechanisms Involved in the Benefits of an Exercise Programme in Patients With Cirrhosis
|
N/A | |
Completed |
NCT01362855 -
Advance Care Planning Evaluation in Hospitalized Elderly Patients
|
||
Active, not recruiting |
NCT01205074 -
¹³C-Methacetin Breath Test (MBT) Methodology Study
|
Phase 2/Phase 3 | |
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Completed |
NCT01231828 -
Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies.
|
N/A |